Cargando…
A Case of Carbamazepine-Induced Aggravation of Self-Limited Epilepsy with Centrotemporal Spikes Epilepsy and Valproate-Induced Hyperammonemic Encephalopathy in a Child with Heterozygous Gene Variant of Carbomoyl Phosphatase Synthetase Deficiency
Antiepileptics drugs are the mainstay of the management of epilepsy in children. Sodium valproate (VPA) and carbamazepine (CBZ) are widely used medications in childhood epilepsy. Hyperammonemia has been described as a known side effect of valproate therapy. It is known that VPA-associated HA is comm...
Autores principales: | Kankananarachchi, Imalke, Jasinge, Eresha, Hewawitharana, Gemunu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741391/ https://www.ncbi.nlm.nih.gov/pubmed/35003817 http://dx.doi.org/10.1155/2021/2362679 |
Ejemplares similares
-
Valproate-Induced Hyperammonemic Encephalopathy
por: Farooq, Faiza, et al.
Publicado: (2017) -
Infrequent Monitoring of the Effects of Valproate and Carbamazepine Therapy in Patients With Epilepsy in Nigeria
por: Eshiet, Unyime Israel, et al.
Publicado: (2020) -
A Case of Valproate Induced Hyperammonemic Encephalopathy
por: Tarafdar, Surjit, et al.
Publicado: (2011) -
Valproate induced hyperammonemic encephalopathy treated by haemodialysis
por: Chauhan, Vinay Singh, et al.
Publicado: (2017) -
A Case of Valproate-Induced Hyperammonemic Encephalopathy
por: Zafar, Faraaz, et al.
Publicado: (2020)